课题基金 / 基金详情

Genetic risks for ALI in ARDSnet and the iSPAAR Consortium

Genetic risks for ALI in ARDSnet and the iSPAAR Consortium
ARDSnet 和 iSPAAR 联盟中的 ALI 遗传风险
批准号:
7939859
负责人:
Mark M Wurfel
金额:
$157.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2012-08-31

项目摘要

项目成果

Mark M Wurfel的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 急性肺损伤(ALI)是脓毒症和创伤的常见并发症,死亡率高达20%以上。候选基因研究表明,常见的基因变异在决定危重病患者的宿主对ALI的易感性中起着重要作用。然而,到目前为止,所研究的变异只占个体在暴露于明显相似的风险因素(如败血症或创伤)后发生ALI风险的一小部分。我们假设,在一项全基因组关联研究中,可以在一大群ALI高危患者中发现与ALI风险增加相关的其他常见基因变异。我们建议利用现有的基因组DNA样本和相关的丰富表型数据,作为ARDSNet联盟临床试验的一部分,在这次全基因组范围内寻找ALI风险等位基因。我们将利用作为iSPAAR(识别易发生ALI风险改变的SNPs)联盟成员进行的研究的一部分而收集的表型良好的样本,为危重患者的基因研究提供前所未有的样本量。通过以下具体目标,我们将为ALI的发病机制提供新的见解,并确定新的ALI风险标记物,这些标记物可以在未来的研究中进行测试,用于风险分层和识别可能从新的治疗干预措施中受益最大的不良结局的高危受试者。我们还将为研究ALI潜在的遗传学风险提供宝贵的新资源,这将促进许多以前由于缺乏足够的样本大小和密集的基因信息而无法进行的未来研究。总而言之,这些贡献将代表着ALI发病机制和预测领域的快速重大进展。 公共卫生相关性: 拟议的研究与人类健康高度相关。我们将调查改变个人对急性肺损伤(ALI)易感性的遗传因素。在美国,ALI每年影响20,000多名患者,与20%-25%的死亡率有关。我们的研究将确定导致ALI发病或严重程度的新基因,这些基因可能成为治疗和风险分层的新靶点。我们正在利用基因调查的力量,朝着护理危重病人的个性化方法迈进。
英文摘要
DESCRIPTION (provided by applicant): Acute Lung Injury (ALI) is a common complication of sepsis and trauma and is associated with mortality rates of over 20%. Candidate gene studies suggest a role for common genetic variation in determining host susceptibility to ALI in critically ill patients. However, variants studied to date account for only a small proportion of the variability in risk of an individual to develop ALI after exposure to apparently similar risk factors such as sepsis or traumatic injury. We hypothesize that additional common genetic variants associated with increased risk for ALI can be discovered in a large group of patients at-risk for ALI using a genome- wide association study (GWAS). We propose to capitalize on existing genomic DNA samples and associated rich phenotypic data collected as part of the ARDSnet consortium clinical trials in this genome-wide search for ALI risk alleles. We will leverage well-phenotyped samples collected as part of studies performed by members of the iSPAAR (identification of SNPs Predisposing to Altered ALI Risk) consortium to provide an unprecedented sample size for a genetic study in the critically ill. Through the following specific aims we will provide new insight on ALI pathogenesis and identify novel markers of risk for ALI that can be tested in future studies for utility in risk stratification and identification of subjects at high-risk for poor outcomes that might benefit most from new therapeutic interventions. We will also generate an invaluable new resource for the study of genetics underlying risk for ALI that will facilitate many future studies that were previously unfeasible given the lack of adequate samples sizes and dense genotypic information. Taken together, these contributions will represent a rapid major advancement in the field of ALI pathogenesis and prediction. PUBLIC HEALTH RELEVANCE: The proposed studies are highly relevant to human health. We will investigate the genetic factors that modify an individual's susceptibility to acute lung injury (ALI), which affects more than 200,000 patients per year in the U.S. and is associated with mortality of 20-25%. Our studies will identify new genes that contribute to the onset or severity of ALI, and these genes could become new targets for treatment and risk stratification. We are using the power of genetic investigation to move towards a personalized approach to the care of critically ill patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic control of gene expression during innate immune activation
  • 批准号:
    7842035
  • 项目类别:
  • 资助金额:
    $24.92万
  • 财政年份:
    2009
  • 负责人:
    Mark M Wurfel
  • 依托单位:
Genetic risks for ALI in ARDSnet and the iSPAAR Consortium
  • 批准号:
    7855586
  • 项目类别:
  • 资助金额:
    $310.34万
  • 财政年份:
    2009
  • 负责人:
    Mark M Wurfel
  • 依托单位:
Genetic control of gene expression during innate immune activation
  • 批准号:
    7299784
  • 项目类别:
  • 资助金额:
    $52.65万
  • 财政年份:
    2007
  • 负责人:
    Mark M Wurfel
  • 依托单位:
Genetic control of gene expression during innate immune activation
  • 批准号:
    7484189
  • 项目类别:
  • 资助金额:
    $53.5万
  • 财政年份:
    2007
  • 负责人:
    Mark M Wurfel
  • 依托单位:
海外基金